A scientist pipetting at a biomedical laboratory on 9 August, 2018. Photo: ALAMY
Opinion
Opinion
Macroscope
Indonesia’s policy misstep is Vietnam’s opportunity to seize the sweet spot as Southeast Asia’s pharmaceutical hub
- Indonesia is actively driving out biopharmaceutical and other sophisticated ventures, requiring the compulsory licensing of any non-indigenous pharmaceutical products
- This intellectual property grab will result in the list of drugs not available in Indonesia to grow even longer
A scientist pipetting at a biomedical laboratory on 9 August, 2018. Photo: ALAMY